We are live on ! Find out more
CM

Crestline Management Portfolio holdings

AUM $46.3M
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
-10.85%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$1.06B
AUM Growth
-$96.4M
Cap. Flow
+$61.7M
Cap. Flow %
5.81%
Top 10 Hldgs %
52.73%
Holding
288
New
112
Increased
38
Reduced
29
Closed
52

Sector Composition

Rank Sector Weight
1 Healthcare 51.62%
2 Financials 19.66%
3 Technology 5.66%
4 Industrials 4.81%
5 Materials 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XPOA
126
DELISTED
DPCM Capital, Inc.
XPOA
$833K 0.08%
85,250
+10,250
+14% +$100K
TW icon
127
Tradeweb Markets
TW
$21.4B
$814K 0.08%
10,084
-9,916
-50% -$855K
LPLA icon
128
LPL Financial
LPLA
$28.3B
$791K 0.07%
+5,044
New +$724K
XAGE
129
DELISTED
Longevity Health Holdings, Inc. Common Stock
XAGE
$726K 0.07%
+2,500
New +$726K
BKI
130
CALL
DELISTED
Black Knight, Inc. Common Stock
BKI
$720K 0.07%
+10,000
New +$768K
ATEC icon
131
CALL
Alphatec Holdings
ATEC
$1.46B
$687K 0.06%
+56,300
New +$785K
PMGM
132
DELISTED
Priveterra Acquisition Corp. II Class A Common Stock
PMGM
$607K 0.06%
61,550
+10,200
+20% +$99.6K
RETA
133
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$594K 0.06%
5,909
-103
-2% -$12.1K
SOFI icon
134
SoFi Technologies
SOFI
$21B
$587K 0.06%
+37,000
New +$580K
VAPO
135
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$561K 0.05%
+3,150
New +$640K
TTWO icon
136
Take-Two Interactive
TTWO
$45.4B
$546K 0.05%
+3,547
New +$575K
QFTA
137
DELISTED
Quantum FinTech Acquisition Corporation
QFTA
$540K 0.05%
54,774
+3,074
+6% +$30K
TLSI icon
138
TriSalus Life Sciences
TLSI
$279M
$535K 0.05%
+53,850
New +$527K
ASAX
139
DELISTED
Astrea Acquisition Corp. Class A Common Stock
ASAX
$513K 0.05%
51,400
ICU icon
140
SeaStar Medical
ICU
$12.5M
$512K 0.05%
204
GRNA
141
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
$511K 0.05%
51,684
TMTS
142
DELISTED
Spartacus Acquisition Corporation Class A Common Stock
TMTS
$511K 0.05%
50,400
SABS icon
143
SAB Biotherapeutics
SABS
$273M
$510K 0.05%
5,061
OSTR
144
DELISTED
Oyster Enterprises Acquisition Corp. Class A Common Stock
OSTR
$508K 0.05%
52,100
FOXO
145
DELISTED
FOXO TECHNOLOGIES INC A
FOXO
$507K 0.05%
258
HGAS
146
DELISTED
Global Gas Corporation Class A Common Stock
HGAS
$507K 0.05%
51,233
AENT icon
147
Alliance Entertainment
AENT
$276M
$506K 0.05%
51,650
ELIQ
148
DELISTED
Electriq Power Holdings, Inc.
ELIQ
$506K 0.05%
51,400
EDTX
149
DELISTED
EdtechX Holdings Acquisition Corp. II Class A common stock
EDTX
$506K 0.05%
50,700
OCAX
150
DELISTED
OCA Acquisition Corp. Class A Common Stock
OCAX
$505K 0.05%
51,002

Similar funds

Crestline Management's Q3 2021 Portfolio in Review

As of Q3 2021, Crestline Management held 288 positions worth $1.06B, down 8.3% from $1.16B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Crestline Management deployed $61.7M of net new capital in Q3 2021, opening 112 new positions and adding to 38 existing holdings. Its largest new stake was Willis Towers Watson: 74,353 shares worth $17.3M.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, down from 62% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Denali Therapeutics, an estimated $24.3M trimmed.

  • Crestline Management's largest Q3 2021 buy was Willis Towers Watson: 74,353 shares worth $17.3M.
  • Crestline Management added most to Bank of America in Q3 2021, an estimated $9.77M increase.
  • Crestline Management's biggest Q3 2021 reduction was Denali Therapeutics, cutting an estimated $24.3M.
  • Crestline Management fully exited Petrobras Class A in Q3 2021, selling an estimated $25M.
  • Crestline Management's ten largest holdings make up 53% of its $1.06B portfolio in Q3 2021.
  • Crestline Management opened 112 new positions and closed 52 in Q3 2021.
  • Crestline Management's portfolio value fell 8.3% quarter-over-quarter to $1.06B.

Based on Crestline Management's 13F filing for Q3 2021, filed 12 Nov 2021.